The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease

A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor   Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation

(2010) R. J. Mourey et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for Inflammatory bowel disease treatment

(2010) Franco Scaldaferri et al.   Cell Adhesion & Migration

Regulation of HSP60 and the role of MK2 in a new model of severe experimental pancreatitis

(2009) Yong-Yu Li et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology

(2009) Sergiy Kostenko et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Differential activation of p38MAPK isoforms by MKK6 and MKK3

(2009) Gaëlle Remy et al.   CELLULAR SIGNALLING

Mitogen activated protein kinases: a role in inflammatory bowel disease?

(2009) O. J. Broom et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease

(2009) Franco Scaldaferri et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

IL1β- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn’s disease

(2009) m. kidd et al.   NEUROGASTROENTEROLOGY AND MOTILITY

MK2: a novel molecular target for anti-inflammatory therapy

(2008) Senthil Duraisamy et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease

(2008) Megan E. Himmel et al.   IMMUNOLOGY